A dermonutrient containing special collagen peptides improves skin structure and function: a randomized, placebo-controlled, triple-blind trial using confocal laser scanning microscopy on the cosmetic effects and tolerance of a drinkable collagen supplement
Decreases Glucagon: Reduces production of glucagon, a hormone that raises blood sugar, preventing unnecessary glucose release from the liver
Ensures a secure fit between the abutment and the implant and establishes a superior primary stability
To be eligible for the BELIEVE study, participants must have a body mass index (BMI) greater than or equal to 30, or greater than or equal to 27 with one or more obesity-related comorbidities
When activated, GLP-1 slows digestion, increases the feeling of fullness, and supports balanced blood sugar levels by making the body more sensitive to insulin
Thus, generalization to all individuals with CUD should be done with caution